Abstract
Transmission of SARS-CoV-2 appears especially effective in “hot zone” locations where individuals interact in close proximity. We present mathematical models describing two types of hot zones. First, we consider a metapopulation model of infection spread where transmission hot zones are explicitly described by independent demes in which the same people repeatedly interact (referred to as “static” hot zones, e.g. nursing homes, food processing plants, prisons, etc.). These are assumed to exists in addition to a “community at large” compartment in which virus transmission is less effective. This model yields a number of predictions that are relevant to interpreting epidemiological patterns in COVID19 data. Even if the rate of community virus spread is assumed to be relatively slow, outbreaks in hot zones can temporarily accelerate initial community virus growth, which can lead to an overestimation of the viral reproduction number in the general population. Further, the model suggests that hot zones are a reservoir enabling the prolonged persistence of the virus at “infection plateaus” following implementation of non-pharmaceutical interventions, which has been frequently observed in data. The second model considers “dynamic” hot zones, which can repeatedly form by drawing random individuals from the community, and subsequently dissolve (e.g. restaurants, bars, movie theaters). While dynamic hot zones can accelerate the average rate of community virus spread and can provide opportunities for targeted interventions, they do not predict the occurrence of infection plateaus or other atypical epidemiological dynamics. The models therefore identify two types of transmission hot zones with very different effects on the infection dynamics, which warrants further epidemiological investigations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Support of grant NSF DMS 1662146/1662096 (NK & DW) is gratefully acknowledged. The authors or their institution never received payment or services from a third party for any aspect of the submitted work
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
This work is based on mathematical models. No data are included.
